Search

everythinglearnresearchcommunity

for

Search:↓

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Scientists have improved 3D models of human skin for research and medical uses, but still face challenges in perfectly replicating real skin.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Several treatments are effective for pigmentary disorders like vitiligo and melasma.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

JAK inhibitors show promise for treating various skin diseases.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

OCT can detect hidden hair follicles in alopecia areata, indicating potential hair regrowth.

Alopecia areata in elderly people is usually mild and responds well to treatment.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

Terbinafine can cause hair loss.

Cyclosporin doesn't stop hair loss.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

People with Alopecia Areata often have lower vitamin D levels, and vitamin D supplements might help treat it.

The visfatin GT genotype may increase the risk of Alopecia Areata.

AB+ blood group is more common in alopecia areata patients.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

The study suggests pandemic stress might worsen or trigger hair loss problems.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.